Beijing Tong Ren Tang Chinese Medicine(03613) Financial Reports - Data and Analysis

Quotes

Detailed Quotes

Company Overview

Company Profile Company Executives

Financial Analysis

Main Composition Key Indicators Financial Statement

Multi-dimentional Analyses

Company Valuation Capital Tracking Short Selling Data

Income statement Balance sheet Cash flow

YOY

Do not show

Hide blank lines

(FY)2021/12/31(Q6)2021/06/30(FY)2020/12/31(Q6)2020/06/30

Turnover

18.31% 1.56B 24.08% 704.03M -8.19% 1.32B -31.01% 567.42M

Operating income

18.31% 1.56B 24.08% 704.03M -8.19% 1.32B -31.01% 567.42M

Cost of sales

-20.44% -436.54M -14.51% -203.87M 13.67% -362.44M 19.76% -178.04M

Operating expenses

-20.44% -436.54M -14.51% -203.87M 13.67% -362.44M 19.76% -178.04M

Gross profit

17.5% 1.12B 28.45% 500.16M -5.91% 952.9M -35.17% 389.38M

Selling expenses

-10.33% -186.37M -16.75% -89.42M 15.16% -168.92M 33.22% -76.6M

Administrative expenses

-- -- -24% -66.67M -- -- 14.35% -53.76M

Special items of operating profit

-35.09% -154.8M -59.65% 3.34M -3783.16% -114.58M 978.39% 8.28M

Operating profit

16.29% 778.46M 29.97% 347.41M 2.67% 669.4M -36.94% 267.3M

Financing income

-79.78% 4.38M -81.19% 2.72M -50.13% 21.65M -34.13% 14.48M

Financing cost

-9.47% -4.71M -12.53% -2.21M -2.21% -4.3M 3.96% -1.96M

Special items of earning before tax

130.35% 261K 115.37% 205K 56.39% -860K -105.23% -1.33M

Earning before tax

13.49% 778.39M 25.01% 348.13M -0.48% 685.9M -37.16% 278.49M

Tax

-7.49% -126.85M -35.39% -57.41M -5.02% -118.01M 41.49% -42.41M

After-tax profit from continuing operations

14.73% 651.54M 23.14% 290.72M -1.56% 567.88M -36.32% 236.08M

Earning after tax

14.73% 651.54M 23.14% 290.72M -1.56% 567.88M -36.32% 236.08M

Minority profit

71.9% 43.71M 147.33% 23.5M 22.62% 25.43M -21.78% 9.5M

Profit attributable to shareholders

12.05% 607.84M 17.94% 267.22M -2.46% 542.46M -36.81% 226.58M

Basic earnings per share

12.31% 0.73 18.52% 0.32 -1.52% 0.65 -37.21% 0.27

Diluted earnings per share

12.31% 0.73 18.52% 0.32 -1.52% 0.65 -37.21% 0.27

Currency Unit

HKDHKDHKDHKD

Accounting Standards

HKASHKASHKASHKAS

Audit Opinions

Unqualified Opinion--Unqualified Opinion--

Auditor

PricewaterhouseCoopers--PricewaterhouseCoopers--

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report，MOM=(current period - last period)/last period *100%

Company Overview More

Beijing Tongrentang Chinese Medicine Co., Ltd. is mainly engaged in the production and sale of traditional Chinese medicine. The company and its subsidiaries operate through three major divisions. Hong Kong, China Branch is engaged in selling Chinese medicine products and health products through retail stores, providing Chinese medicine diagnostic services and wholesale Chinese medicine products in Hong Kong, China. It is also engaged in managing brand royalties paid by overseas entities that use the "Tongrentang" brand. The mainland China division distributes Tongrentang Technology and Tongrentang brand products exclusively to non-mainland customers in mainland China. Overseas branches retail and wholesale traditional Chinese medicine products and health products in other overseas countries, and provide Chinese medicine diagnosis and treatment services.

CEO： Yongling Ding

Market： Hong Kong motherboard

Hot List

TradeSearchNews

SymbolLatest price%Chg